Sign in
Pharma
Biotech
Medical devices
Veterinary
Inspection insights
Knowledge hub
Resource center
Glossary
Regulators & Associations
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Menu
Explore the website
Get email updates with every new article published
Sign Up
I've read and accept the
Privacy Policy
and the
Terms of Service
.
Search
Looking for something?
Search
Menu
Explore the website
Get email updates with every new article published
Sign Up
I've read and accept the
Privacy Policy
and the
Terms of Service
.
Search
Looking for something?
Search
Tuesday, 10 November, 2026
Regulatory insights
powered by
GMP-inspection.com
Email us
Menu
Explore the website
Get email updates with every new article published
Sign Up
I've read and accept the
Privacy Policy
and the
Terms of Service
.
Looking for something?
Search
Pharma
Biotech
Medical devices
Veterinary
Inspection insights
About us
Contact us
Preparing for a GMP inspection?
Ensure compliance with our professional translation services by GMP-inspection.com
Learn more ⟶
Sample Category Title
Sample Category I
Sample Category II
Sample Category III
Sample Category IV
Kazakhstan to undergo PIC/S on-site assessment in 2027
Regulatory Affairs
TOP-Pharma Editorial Team
-
9 November 2026
Kazakhstan has been approved for an on-site assessment mission and an observed inspection in 2027 as part of its application for membership of the...
China’s revised medical device GMP takes effect, strengthening quality and contract manufacturing requirements
Medical Devices
TOP-Pharma Editorial Team
-
9 November 2026
China’s National Medical Products Administration (NMPA) put its revised Good Manufacturing Practice (GMP) for Medical Devices into effect on 1 November 2026. Issued under...
FDA proposes framework for individualized gene therapies as CMS expands access
Biotech
TOP-Pharma Editorial Team
-
29 October 2026
Clopidogrel oral liquids recall: assay control, OOS investigation and batch impact assessment
Inspection Insights
TOP-Pharma Editorial Team
-
27 October 2026
FDA inspections: who will inspect your site — and who decides the outcome?
Inspection Insights
TOP-Pharma Editorial Team
-
26 October 2026
UK announces AI Biosecurity Lab with up to £300 million in public and industry support
Pharma
TOP-Pharma Editorial Team
-
25 October 2026
Who will inspect your pharmaceutical site? A guide to the global GMP inspection landscape
Inspection Insights
TOP-Pharma Editorial Team
-
24 October 2026
Council of Europe proposes regulatory framework for human organs manipulated ex situ
Advanced Therapies
TOP-Pharma Editorial Team
-
23 October 2026
Load more